학술논문

How Managed Entry Agreements Influence the Patients' Affordability to Biological Medicines—Bulgarian Example.
Document Type
Article
Source
Healthcare (2227-9032); Sep2023, Vol. 11 Issue 17, p2427, 13p
Subject
HEALTH care industry
BIOLOGICAL products
ECONOMIC impact
BULGARIANS
MEDICAL care costs
COST control
HEALTH insurance reimbursement
DESCRIPTIVE statistics
RESEARCH funding
PHARMACEUTICAL industry
PUBLIC spending
Language
ISSN
22279032
Abstract
Copyright of Healthcare (2227-9032) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)